You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Gangliosidosis, GM1

Showing 1 - 25 of 7,876
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Infantile and Juvenile GM1 Gangliosidosis (GM1) Patients

Recruiting
  • GM1 Gangliosidosis
    • Oakland, California
    • +5 more
    Feb 2, 2023

    Lysosomal Diseases, Gangliosidosis, GM1 Trial run by the NHGRI (biological, drug, diagnostic test, other, procedure, behavioral)

    Recruiting
    • Lysosomal Diseases
    • +2 more
    • AAV9-GLB1
    • +20 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 19, 2023

    GM1 and GM2 Gangliosidosis PROspective Neurological Disease

    Recruiting
    • GM1 Gangliosidosis
    • +2 more
      • Oakland, California
      • +12 more
      Nov 16, 2022

      GM1 Gangliosidosis, GM1 Gangliosidosis, Type I, GM1 Gangliosidosis, Type 2 Trial in Worldwide (PBGM01)

      Recruiting
      • GM1 Gangliosidosis
      • +3 more
      • PBGM01
      • Oakland, California
      • +9 more
      Mar 10, 2022

      Interviews and Video Capture in Patients With GM1 Gangliosidosis

      Recruiting
      • GM1 Gangliosidosis
      • Natural history
      • Plymouth, Massachusetts
        Casimir Trials
      Aug 23, 2021

      A Natural History Study of the Gangliosidoses

      Recruiting
      • Tay-Sachs Disease
      • +4 more
        • Minneapolis, Minnesota
          University of Minnesota - Pediatric Genetics and Metabolism
        Feb 28, 2022

        Brain Metastases, Radiotherapy Side Effect, Cognitive Impairment Trial in Guangzhou (Monosialotetrahexosyl ganglioside (GM1),

        Recruiting
        • Brain Metastases
        • +4 more
        • Monosialotetrahexosyl ganglioside (GM1)
        • Control
        • Guangzhou, Guangdong, China
          Sun Yat-sen University Cancer Center
        Nov 3, 2021

        GM2 Gangliosidosis, Niemann-Pick Disease, Type C Trial in Curitiba, Porto Alegre, Rio De Janeiro (AZ-3102 (Dose 1), Placebo,

        Not yet recruiting
        • GM2 Gangliosidosis
        • Niemann-Pick Disease, Type C
        • AZ-3102 (Dose 1)
        • +2 more
        • Curitiba, Brazil
        • +2 more
        Feb 24, 2023

        GM1 Gangliosidosis Trial in Orange, Paris, Manchester (LYS-GM101)

        Recruiting
        • GM1 Gangliosidosis
        • LYS-GM101
        • Orange, California
        • +2 more
        Jun 30, 2021

        Infantile GM2 Gangliosidosis (Disorder) Trial in Kingston (TSHA-101)

        Active, not recruiting
        • Infantile GM2 Gangliosidosis (Disorder)
        • TSHA-101
        • Kingston, Ontario, Canada
          Queen's University/Kingston Health Sciences Centre
        Sep 12, 2022

        The Natural History of Metachromatic Leukodystrophy

        Recruiting
        • MLD
        • +26 more
        • Palliative Care
        • Hematopoetic Stem Cell Transplantation
        • Pittsburgh, Pennsylvania
          The Program for the Study of Neurodevelopment in Rare Disorders,
        Nov 2, 2021

        ScreenPlus: A Comprehensive, Flexible, Multi-disorder Newborn

        Enrolling by invitation
        • Acid Sphingomyelinase Deficiency
        • +13 more
        • Confirmatory Testing
        • Bronx, New York
        • +9 more
        May 9, 2022

        Gangliosidoses, GM1 Gangliosidosis, Morquio B Disease Trial in Hochheim

        Recruiting
        • Gangliosidoses
        • +8 more
          • Hochheim, HE, Germany
            SphinCS Lyso gemeinnützige UG (haftungsbeschränkt)
          Nov 5, 2020

          GM1 Gangliosidoses, GM2 Gangliosidoses, Tay-Sachs Disease Trial in Minneapolis (miglustat, Ketogenic Diet)

          Terminated
          Has Results
          • GM1 Gangliosidoses
          • +3 more
          • Minneapolis, Minnesota
            University of Minnesota
          Mar 18, 2021

          Biomarker for Gangliosidosis: BioGM1/BioGM2 (BioGM1/GM2)

          Active, not recruiting
          • Hepato-splenomegaly
          • +3 more
            • Cairo, Egypt
            • +4 more
            May 12, 2021

            Tay-Sachs Disease Sandhoff Disease Trial in Worldwide (venglustat GZ402671, )

            Active, not recruiting
            • Tay-Sachs Disease Sandhoff Disease
            • venglustat GZ402671
            • placebo
            • Los Angeles, California
            • +23 more
            Jan 31, 2022

            GM2 Gangliosidosis, Supportive Care Trial in Kashan, Mashhad, Tehran (Miglustat)

            Recruiting
            • GM2 Gangliosidosis
            • Supportive Care
            • Kashan, Isfahan, Iran, Islamic Republic of
            • +2 more
            Oct 23, 2022

            Anatomic Stage IV Breast Cancer AJCC v8, Chemo-Induced Peripheral Neuropathy, Metastatic Breast Carcinoma Trial (Paclitaxel,

            Not yet recruiting
            • Anatomic Stage IV Breast Cancer AJCC v8
            • +2 more
            • (no location specified)
            Feb 21, 2023

            To Evaluate the Effectiveness of GM1 in the Prevention of Albumin-paclitaxel Therapy Induced Peripheral Neuropathy in Breast

            Not yet recruiting
            • To Evaluate the Effectiveness of GM1 in the Prevention of Albumin-paclitaxel Therapy Induced Peripheral Neuropathy in Breast Cancer Patients
            • Monosialotetrahexose ganglioside sodium injection
            • (no location specified)
            Mar 27, 2023

            Glycosphingolipid and Glycoprotein Lysosomal Storage Disorders

            Recruiting
            • Neurological Regression
            • +3 more
              • Bethesda, Maryland
                National Institutes of Health Clinical Center
              Jan 14, 2023

              Breast Cancer Trial in Guangzhou (Ganglioside-monosialic acid, )

              Completed
              • Breast Cancer
              • Ganglioside-monosialic acid
              • placebo
              • Guangzhou, Guangdong, China
                Sun Yat-sen University Cancer Center
              Nov 3, 2021

              Objective Response Rate Trial in Wuhan (GM-CSF)

              Recruiting
              • Objective Response Rate
              • Wuhan, Hubei, China
                Renmin Hospital of Wuhan University
              Feb 25, 2023

              Early Breast Cancer Trial in Zhengzhou (monosialic gangliosides, Placebo)

              Withdrawn
              • Early Breast Cancer
              • monosialic gangliosides
              • Placebo
              • Zhengzhou, Henan, China
                Henan Cancer Hospital
              Nov 19, 2022

              Adrenoleukodystrophy, Metachromatic Leukodystrophy, Globoid Cell Leukodystrophy Trial in Minneapolis (drug, procedure,

              Completed
              Has Results
              • Adrenoleukodystrophy
              • +8 more
              • Minneapolis, Minnesota
                Masonic Cancer Center, University of Minnesota
              Jul 10, 2019

              Stroke, Ischemic Trial in Shenyang (Monosialoganglioside GM1)

              Recruiting
              • Stroke, Ischemic
              • Monosialoganglioside GM1
              • Shenyang, Liaoning, China
                General Hospital of ShenYang Military Region
              Aug 10, 2021